title: n-3 NEFA: vascular implications.
authors.forename: P G
authors.initials: PG
authors.lastname: Fegan
authors.forename: K M
authors.initials: KM
authors.lastname: Macleod
authors.forename: J E
authors.initials: JE
authors.lastname: Tooke
authors.forename: A C
authors.initials: AC
authors.lastname: Shore
mesh_terms: D001095:Arachidonic Acids / Q000097:blood / Q000494:pharmacology; D001775:Blood Circulation / Q000187:drug effects / Q000502:physiology; D002318:Cardiovascular Diseases / Q000097:blood / Q000503:physiopathology; D008076:Cholesterol, HDL / Q000097:blood / Q000187:drug effects; D008078:Cholesterol, LDL / Q000097:blood / Q000187:drug effects; D004730:Endothelium, Vascular / Q000187:drug effects / Q000502:physiology; D015525:Fatty Acids, Omega-3 / Q000097:blood* / Q000494:pharmacology*; D006801:Humans; D012907:Smoking / Q000009:adverse effects; D014280:Triglycerides / Q000097:blood
chemical_list: D001095:Arachidonic Acids; D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D015525:Fatty Acids, Omega-3; D014280:Triglycerides